Preferred Label : Bevacizumab/Tipiracil/Trifluridine Regimen;
NCIt synonyms : Lonsurf Plus Avastin Regimen; Bevacizumab/Tipiracil/Trifluridine; Trifluridine/Tipiracil/Bevacizumab; Bevacizumab Plus Tipiracil/Trifluridine Regimen; Trifluridine/Tipiracil Plus Bevacizumab; Trifluridine/Tipiracil Plus Bevacizumab Regimen; Bevacizumab-Tipiracil-Trifluridine;
NCIt related terms : Trifluridine and tipiracil and Bevacizumab; Trifluridine and tipiracil and Bevacizumab-bvzr; Trifluridine and tipiracil and Bevacizumab-aybi; Trifluridine and tipiracil and Bevacizumab-equi; Trifluridine and tipiracil and Bevacizumab-awwb; Trifluridine and tipiracil and Bevacizumab-adcd; Trifluridine and tipiracil and Bevacizumab-onbe; Trifluridine and tipiracil and Bevacizumab-maly;
NCIt definition : A regimen consisting of bevacizumab, tipiracil and trifluridine that may be used in
the treatment of appendiceal adenocarcinoma and colorectal cancers.;
NCI Metathesaurus CUI : CL1778893;
Codes from synonyms : 18840; 127407; 127629; 127481; 127185; 127333; 127555; 127259;
Origin ID : C186515;
UMLS CUI : C5670601;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
